Therapeutic agents
harboring both wound healing and antibacterial
activities have much demand in biomedical applications. Development
of such candidates with clinically approved materials adds more advantages
toward these applications. Recently, silver metal complex nanomaterials
have been playing a major role in medical uses especially for antibacterial
activity and wound healing. In this report, we designed and synthesized
silver nitroprusside complex nanoparticles (abbreviated as AgNNPs)
using sodium nitroprusside and silver nitrate (both are FDA approved
precursors). The nanoparticles (AgNNPs) were thoroughly characterized
by various physicochemical techniques such as XRD, FTIR, TGA, DLS,
EDAX, Raman, ICP-OES, HRTEM, and FESEM. The cell viability assay in
normal cells (EA.hy 926 cells, NIH 3T3) using MTT reagents and CEA
assay (CEA: Chick embryo angiogenesis assay) in fertilized eggs demonstrate
the biocompatibility of AgNNPs. These nanoparticles show effective
antibacterial activity against both Gram positive and Gram negative
bacteria through membrane and DNA damage. Additionally, AgNNPs accelerate
the wound healing in C57BL6 mice by altering the macrophages from
M1 to M2. Considering the results together, the current study may
offer the development of new silver nanocomplex nanomaterials that
shows synergistic effect on antibacterial activity and wound healing
(2-in-1-system). To the best of our knowledge, this is the first report
for the synthesis, characterization, and biomedical applications of
silver nitroprusside nanoparticles.